BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Quanterix Launches First-to-Market p‑Tau 205 and 212 Assays, Expanding Alzheimer’s Biomarker Portfolio

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, announced the first to market, com...

August 01, 2025 | News

Shanton Pharma’s SAP-001 Receives FDA Fast Track Designation for Refractory Gout Treatment

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, announced that FDA has designated its Investigational New Dru...

July 28, 2025 | News

Suzhou’s Kintor Pharma Reports Positive Phase II Results for KX-826 in AGA Trial, Clears Path for Phase III

Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and po...

July 28, 2025 | News

Sarepta Therapeutics Reaffirms Commitment to Patient Safety Following FDA Update on Unrelated Fatality

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, issued the following statement in response to an FDA...

July 28, 2025 | News

GNT Pharma Receives South Korea’s Green Light to Launch Global Phase 3 Trials for Breakthrough Stroke Drug Nelonemdaz

GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced its IND Application to commence Glo...

July 25, 2025 | News

Akeso Enrols First Patient in Phase III Trial of Ivonescimab for Metastatic Pancreatic Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase II...

July 24, 2025 | News

QIAGEN Expands QIAseq Portfolio with Launch of Long Read Panels to Enhance Complex Genomic Analysis

Expansion of QIAseq portfolio to Long Read Panels enables high-resolution analysis of complex genomic regions using long-read sequencing Supports NGS ...

July 23, 2025 | News

China’s DualityBio Secures FDA Fast Track for Next-Gen HER3 ADC DB-1310 in Advanced Lung Cancer

DualityBio announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to its next-generation HER3-targeting a...

July 23, 2025 | News

10x Genomics and A*STAR GIS Join Forces to Advance Precision Medicine Through AI-Powered Spatial Biology

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), announced a resea...

July 21, 2025 | News

Hyphens Pharma Launches Winlevi® in Singapore and Malaysia, Ushering in a New Era of Acne Treatment in Southeast Asia

Hyphens Pharma Pte. Ltd., a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 18, 2025 | News

GC Biopharma Secures Vietnam Approval for Antibiotic-Free Varicella Vaccine BARYCELA

GC Biopharma (006280.KS), a South Korean pharmaceutical company, announced that its varicella vaccine BARYCELA has received marketing authorization from th...

July 18, 2025 | News

SK bioscience Pioneers Korea’s First Adjuvanted Flu Vaccine with IND Filing for NBP607B

Company aims for technology advancement and platform expansion with Korea's first influenza vaccine using an adjuvant Interim results from the Phase 1/2...

July 18, 2025 | News

Senhwa Biosciences’ CX-5461 Selected by U.S. National Cancer Institute for Major Oncology Research Programme

Senhwa Biosciences, Inc., a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, ...

July 17, 2025 | News

GHIT Fund Commits JPY 1 Billion to Combat Malaria and Tuberculosis Through Global R&D Partnerships

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in ...

July 17, 2025 | News

Stay Connected